Status:
UNKNOWN
Analysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical Exercise
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Conditions:
Resistance Training
Sport Performance
Eligibility:
MALE
20-30 years
Phase:
PHASE4
Brief Summary
This study have like aim to examine whether insulin secretagogues have a potential ergogenic effect leading to a better exercise performance and post-exercise recovery in healthy individuals after a r...
Detailed Description
The use of performance-enhancing drugs is a major area of concern for high-performance athletes because it may lead to serious health problems. It is also quite concerning that these substances are al...
Eligibility Criteria
Inclusion
- continuously resistance-trained for 2 years or more
- minimum frequency of 3 weekly sessions
- preceding 6 months
Exclusion
- self-reported acute or chronic use of drugs including anabolic androgenic steroids, anti-inflammatory drugs, beta-blockers and exogenous insulin for the last 12 months
- alcohol intake within 72 hours of the study intervention
- injuries to bones and muscles preventing physical exercise
- non-adherence to dietary recommendations as instructed by the research team
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04443777
Start Date
June 1 2020
End Date
September 1 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundação Universitária de Cardiologia/ Instituto de Cardiologia
Porto Alegre, Rio Grande do Sul, Brazil, 90040-371